E V Loftus Jr
Overview
Explore the profile of E V Loftus Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peyrin-Biroulet L, Bossuyt P, Bettenworth D, Loftus Jr E, Anjie S, DHaens G, et al.
Dig Dis Sci
. 2024 Mar;
69(5):1808-1825.
PMID: 38499736
Background: Infliximab and vedolizumab are widely used to treat Crohn's disease (CD) and ulcerative colitis (UC). Aims: This systematic review and network meta-analysis evaluated comparative efficacy of various regimens for...
2.
Tse C, Loftus Jr E, Raffals L, Gossard A, Lightner A
Aliment Pharmacol Ther
. 2018 Aug;
48(5):578-579.
PMID: 30156321
No abstract available.
3.
Tse C, Loftus Jr E, Raffals L, Gossard A, Lightner A
Aliment Pharmacol Ther
. 2018 May;
48(2):190-195.
PMID: 29808485
Background: Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic biliary disease associated with inflammatory bowel disease (IBD) with no known cure. Aim: To evaluate the effect of biological therapies...
4.
Lightner A, McKenna N, Tse C, Raffals L, Loftus Jr E, Mathis K
Aliment Pharmacol Ther
. 2017 Dec;
47(5):573-580.
PMID: 29250800
Background: Up to 80% of patients with Crohn's disease require an abdominal operation in their lifetime. As the use of vedolizumab is increasing for the treatment of Crohn's disease, it...
5.
Singh S, Andersen N, Andersson M, Loftus Jr E, Jess T
Aliment Pharmacol Ther
. 2017 Dec;
47(5):596-604.
PMID: 29239001
Background: There are conflicting data on comparative effectiveness of adalimumab and infliximab in patients with Crohn's disease (CD). Aims: To compare the effectiveness and safety of adalimumab and infliximab in...
6.
Cotter T, Kamboj A, Hicks S, Tremaine W, Loftus Jr E, Pardi D
Aliment Pharmacol Ther
. 2017 Aug;
46(6):636.
PMID: 28805323
No abstract available.
7.
Moon W, Loftus Jr E
Aliment Pharmacol Ther
. 2016 Feb;
43(8):863-883.
PMID: 26876431
Background: Azathioprine and mercaptopurine have a pivotal role in the treatment of inflammatory bowel disease (IBD). However, because of their complex metabolism and potential toxicities, optimal use of biomarkers to...
8.
Gupta A, Loftus Jr E, De Felice K, Khanna S
Aliment Pharmacol Ther
. 2015 Dec;
43(1):176.
PMID: 26638940
No abstract available.
9.
Gupta A, De Felice K, Loftus Jr E, Khanna S
Aliment Pharmacol Ther
. 2015 Sep;
42(8):1032-3.
PMID: 26374261
No abstract available.
10.
Peyrin-Biroulet L, Sandborn W, Sands B, Reinisch W, Bemelman W, Bryant R, et al.
Am J Gastroenterol
. 2015 Aug;
110(9):1324-38.
PMID: 26303131
Objectives: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets...